Depresión y ansiedad en la calidad de vida en pacientes con fibrosis pulmonar
No hay miniatura disponible
Fecha
2021
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Escuela de Graduados
Resumen
La Fibrosis pulmonar es una enfermedad crónica, irreversible y de mal pronóstico,
que hace susceptible al paciente de padecer síntomas ansiosos y depresivos que influyen
negativamente en la evolución y la calidad de vida en la salud percibida por el paciente. El
presente trabajo de investigación tiene como objetivo general determinar la ansiedad y
depresivos en la CVRS en pacientes con fibrosis pulmonar, se realizó un estudio
descriptivo correlacional no experimental, observacional, transversal y prospectivo en el
periodo de noviembre del 2019 hasta noviembre 2020. Resultados se obtuvieron de una
muestra de 60 pacientes con fibrosis pulmonar con mayor prevalencia en el sexo femenino
con predomino de la edad media de 60 años cuya tasa de letalidad de 0.31 por cada 100
pacientes, asociada de manera frecuente a las comorbilidades como HTA y diabetes. La
prevalencia de ansiedad y depresión fue de 0.2 y 0.35 según la escala de HADS
respectivamente. El promedio de puntuación para la medida física de 41.7 y para la medida
mental de 50.3 en el cuestionario SF-36. Concluimos que la presencia de síntomas ansiosos y
depresivos son evidentes en los pacientes con FP lo cual es innegable que afecta
considerablemente a calidad de vida de nuestros pacientes.
Palabras claves: depresión, ansiedad, fibrosis pulmonar, prevalencia y Calidad de
vida relacionada a la salud
Pulmonary fibrosis is a chronic, irreversible and poorly prognostic disease that makes the patient susceptible to anxious and depressive symptoms that negatively influence the evolution and quality of life in the health perceived by the patient. The general objective of this research work is to determine anxiety and depressives in CVRS in patients with pulmonary fibrosis, a descriptive, non-experimental, observational, cross-sectional and prospective, correlal stydy will be conducted in the period November 2019 to November 2020. Results were obtained from a sample of 60 patients with pulmonary fibrosis with a higher prevalence in females, with a higher prevalence in females, with a predominance of the mean age of 60 years, with a fatality rate of 0,31 per 100 patients, frequently associated with comorbidities such as hypertension and diabetes. The prevalence of anxiety and depression was 0,2 and 0,35 according to the HADS scale, respectively. The average score for the physical measure of 41.7 and for the mental measure of 50,3 in the Sf-36 questionnaire. We conclude that the presence of anxiety and depressive symptoms are evident in patients with PF, which is undeniable that it considerably affects the quality of life of our patients. Key words: depression, anxiety, pulmonary fibrosis, prevalence and Health-related quality of life
Pulmonary fibrosis is a chronic, irreversible and poorly prognostic disease that makes the patient susceptible to anxious and depressive symptoms that negatively influence the evolution and quality of life in the health perceived by the patient. The general objective of this research work is to determine anxiety and depressives in CVRS in patients with pulmonary fibrosis, a descriptive, non-experimental, observational, cross-sectional and prospective, correlal stydy will be conducted in the period November 2019 to November 2020. Results were obtained from a sample of 60 patients with pulmonary fibrosis with a higher prevalence in females, with a higher prevalence in females, with a predominance of the mean age of 60 years, with a fatality rate of 0,31 per 100 patients, frequently associated with comorbidities such as hypertension and diabetes. The prevalence of anxiety and depression was 0,2 and 0,35 according to the HADS scale, respectively. The average score for the physical measure of 41.7 and for the mental measure of 50,3 in the Sf-36 questionnaire. We conclude that the presence of anxiety and depressive symptoms are evident in patients with PF, which is undeniable that it considerably affects the quality of life of our patients. Key words: depression, anxiety, pulmonary fibrosis, prevalence and Health-related quality of life
Descripción
PDF
Palabras clave
Depresión, Ansiedad, Calidad de vida, Fibrosis pulmonar, Estudios prospectivos, Hospital de Especialidades Dr. Teodoro Maldonado Carbo, Cantón Guayaquil, Ecuador